Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3275 of 3546 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/12/13
End: 11/03/21
Due: 11/03/22
Phase: N/A
Priority: Normal
Start: 08/31/02
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 10/13/10
End: 02/18/11
Due: 02/18/12
Phase: N/A
Priority: Normal
Start: 07/01/08
End: 11/16/10
Due: 11/16/11
Phase: N/A
Priority: Normal
Start: 03/01/16
End: 05/12/16
Due: 05/12/17
Phase: N/A
Priority: Normal
Start: 08/24/05
End: 07/06/06
Due: 07/06/07
Phase: N/A
Priority: Normal
Start: 11/24/03
End: 12/21/04
Due: 12/21/05
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 07/17/23
Due: 07/17/24
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 09/30/09
Due: 09/30/10
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 07/29/24
End: 10/24/24
Due: 10/24/25
Phase: N/A
Priority: Normal
Start: 01/26/11
End: 04/08/11
Due: 04/08/12
Phase: N/A
Priority: Normal
Start: 05/31/10
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 09/23/13
End: 01/11/16
Due: 01/11/17
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 10/31/08
Due: 10/31/09
Phase: N/A
Priority: Normal
Start: 12/01/08
End: 10/17/13
Due: 10/17/14
A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 05/31/08
Due: 05/31/09
Phase: N/A
Priority: Normal
Start: 04/01/06
End: 11/25/06
Due: 11/25/07
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 11/30/06
Due: 11/30/07
Phase: N/A
Priority: Normal
Start: 11/11/14
End: 09/01/15
Due: 09/01/16
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 12/14/21
End: 02/08/29
Due: 02/08/30
Phase: N/A
Priority: Normal
Start: 05/31/17
End: 12/31/18
Due: 12/31/19